Tilray

Tilray Brands, Inc., founded in 2013 by Brendan Kennedy, is a global cannabis and hemp company headquartered in New York City. The company specializes in the research, cultivation, processing, and distribution of cannabis and hemp products, including whole flower, oils, and extracts. Tilray's core mission is to provide high-quality cannabis products to patients, physicians, pharmacies, hospitals, governments, and researchers worldwide. Their market focus spans both medical and recreational cannabis sectors, aiming to improve patient care and expand access to cannabis-based treatments.

Notable figures associated with Tilray include CEO Irwin D. Simon. The company is publicly traded on both Nasdaq and TSX under the ticker symbol TLRY. Tilray has achieved significant milestones, such as generating $627 million in revenue in 2023 and employing around 1,600 people. Its impact is evident in its broad market reach and contributions to cannabis research and development. Through strategic partnerships and a commitment to innovation, Tilray has positioned itself as a leader in the global cannabis industry.